Dr. Andrea D. Sullivan urges Americans to rethink the Ozempic craze and address the root cause: a lack of education about food and lifesty ...

Novo Nordisk NVO shares have gained 5.8% in a week. The uptrend in the stock price was driven by reports of an activist hedge ...

Wondering how to feel about Ozempic? These unexpected questions help reveal what may really be driving your reaction and how ...

Hims and Hers stock rally looms with bullish EMAs, Novo Nordisk partnership, ZAVA acquisition, and new product launches ...

While some compounding pharmacies have stopped making alternatives to Wegovy and Zepbound since shortages were declared over, ...

A MUM-of-two who used to cancel nights out because she felt like “the fat one” has lost two stone in two months by using Mounjaro. Sarah Hill, 32, from Glasgow, is among the estimated 1.5 million ...

Eli Lilly's drug, called eloralintide, helped some patients lose more than 11% of their body weight in three months.

An investigational drug developed by Eolo Pharma is showing promise in animal experiments and an early human trial. It could eventually be an alternative or add-on to popular GLP-1 medications.

What's new in wellness and beauty? Oatzempic—the trending oat smoothie trend that's being called a natural dupe for Ozempic.

Plastic surgeon Dr Benjamin Wabwire explains the current landscape of clinical weight management and why deeper scrutiny is ...

Former FDA chief Dr. David Kessler says the new weight-loss drugs are a powerful tool to fight obesity. But they come with ...

Variants of obesity-related genes influence how much weight patients lose on specific weight loss drugs like liraglutide, two studies report.